LONDON, March 27 Thu Mar 27, 2014 3:23am EDT
* Received final UK regulatory and ethical approvals to commence two new clinical trials
* Phase II clinical trial in stroke disability, recruiting up to 41 patients and treating 8-12 weeks post-stroke, regarded as the optimum treatment window for efficacy
* Received final UK regulatory and ethical approvals to commence two new clinical trials
* Phase II clinical trial in stroke disability, recruiting up to 41 patients and treating 8-12 weeks post-stroke, regarded as the optimum treatment window for efficacy
via Smart Health Shop Forum http://ift.tt/1hxdIjr
No comments:
Post a Comment